Comparing Hypothermic Temperatures During Hemiarch Surgery

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Ottawa Heart Institute Research Corporation
Study ID
NCT02860364
Status
Recruiting

Conditions

  • Thoracic Aortic Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hypothermic circulatory arrest — PROCEDURE
    During cardiac surgery requiring circulatory arrest, the patient's body temperature is lowered significantly to reduce the cellular metabolic rate and reduce ischemic injury.

Study Details

Hypothermic circulatory arrest is an important surgical technique, allowing complex aortic surgeries to be performed safely. Hypothermic circulatory arrest provides protection to cerebral and visceral organs, but may result in longer cardiopulmonary bypass times during surgery, increased risks of bleeding, inflammation, and neuronal injury. To manage these consequences, a trend towards warmer core body temperatures during circulatory arrest has emerged. This trial will randomize patients to either mild (32°C) or moderate (26°C) hypothermia during aortic hemiarch surgery to determine if mild hypothermia reduces the length of cardiopulmonary bypass time and other key measures of morbidity and mortality.

Key Dates

Start date
Feb 20, 2018
Status verified
Sep 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
282 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Mild Hypothermic Circulatory Arrest
    During aortic hemiarch surgery, mild hypothermia (32°C) will be used during circulatory arrest.
  • Active Comparator: Moderate Hypothermic Circulatory Arrest
    During aortic hemiarch surgery, moderate hypothermia (26°C) will be used during circulatory arrest.

Primary Outcome Measure

Composite endpoint of neurologic and acute kidney injury [ Time Frame: Up to 90 days after surgery. ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Massachusetts GeneralBostonMassachusetts02114
Arminder Jassar, MD (PRINCIPAL_INVESTIGATOR)
The Valley HospitalRidgewoodNew Jersey07450
Juan Grau, MD (SUB_INVESTIGATOR)
Jabagi Habib, MD (PRINCIPAL_INVESTIGATOR)
Ohio State University Medical CenterColumbusOhio43210
Jovan Bozinovski, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA